PROSPECTUS SUPPLEMENT
(To prospectus dated June 17, 2020)
20,000,000 CLASS A COMMON SHARES
We are offering 10,000,000 Class A common shares of beneficial interest, $0.01 par value per share (“Class A common shares”).
In addition, we have entered into forward sale agreements with each of Bank of America, N.A. and JPMorgan Chase Bank, National Association, whom we refer to in such capacity individually as a “Forward Purchaser” and collectively as “Forward Purchasers.” In connection with the forward sale agreements, each of BofA Securities, Inc. and J.P. Morgan Securities LLC, or their respective affiliates, whom we refer to in such capacity individually as a “Forward Seller” and collectively as “Forward Sellers,” are borrowing from third parties and selling to the underwriters an aggregate of 10,000,000 Class A common shares that will be delivered in this offering.
We will receive proceeds from the sale of 10,000,000 Class A common shares offered by us in this offering, but we will not initially receive any proceeds from the sale of our Class A common shares by the Forward Sellers in connection with the forward sale agreements. We expect to physically settle the forward sale agreements, which would involve the issuance and delivery by us of Class A common shares against payment by the Forward Purchasers for those shares on one or more closing dates, which we expect to occur no later than January 20, 2023. We may also elect to cash settle or net share settle all or a portion of our obligations under a forward sale agreement if we conclude it is in our best interest to do so. If we elect to cash settle a forward sale agreement, we may not receive any proceeds, and we may owe cash to the relevant Forward Purchaser in certain circumstances. If we elect to net share settle a forward sale agreement, we will not receive any proceeds, and we may owe Class A common shares to the relevant Forward Purchaser. See “Underwriting (Conflicts of Interest)—Sales Through Forward Sellers.” If any Forward Purchaser does not sell on the anticipated closing date all of the Class A common shares to be sold by it to the underwriters, we will issue and sell to the underwriters a number of Class A common shares equal to the number of Class A common shares that the Forward Purchaser did not sell and the number of shares underlying the relevant forward sale agreement will be decreased in respect of the number of shares that we issue and sell.
Our Class A common shares trade on the New York Stock Exchange (the “NYSE”) under the symbol “AMH.” On January 19, 2022, the last sale price of the Class A common shares as reported on the NYSE was $41.21 per share.
We are organized and conduct our operations to qualify as a real estate investment trust (“REIT”) for U.S. federal income tax purposes. To assist us in complying with certain federal income tax requirements applicable to REITs, our charter contains certain restrictions relating to the ownership and transfer of our capital stock, including an ownership limit of 8.0% (in value or in number of shares, whichever is more restrictive) of our outstanding common shares. See “Restrictions on Ownership and Transfer” in the accompanying prospectus.
Investing in our Class A common shares involves certain risks. See “Risk Factors” beginning on page S-8 of this prospectus supplement and in the reports we file with the Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended, incorporated by reference in this prospectus supplement and the accompanying prospectus, to read about factors you should consider before making an investment in our Class A common shares.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
| | | | | | | | |
| | Per Share | | | Total(1) | |
Public offering price | | $ | 39.150 | | | $ | 783,000,000 | |
Underwriting discount(2) | | $ | 1.566 | | | $ | 31,320,000 | |
Proceeds, before expenses, to us(3) | | $ | 37.584 | | | $ | 751,680,000 | |
(1) | Assumes no exercise of the underwriters’ option to purchase additional shares described below. |
(2) | See “Underwriting (Conflicts of Interest)” for additional information regarding underwriting compensation. |
(3) | We expect to receive estimated aggregate proceeds, before expenses, of approximately $375.8 million from the sale of Class A common shares in this offering by us. At an initial forward sale price of $37.584 per share (which is the public offering price per share, less the underwriting discount per share), in the event of full physical settlement of the forward sale agreements, we would receive additional proceeds, before expenses, of approximately $375.8 million pursuant to the forward sale agreements (or approximately $488.6 million if the underwriters exercise their option to purchase additional shares in full), subject to the price adjustment and other provisions of the forward sale agreements. For the purposes of calculating the aggregate proceeds to us from the sale of Class A common shares, we have assumed that the forward sale agreements are fully physically settled in one or more settlements based on the initial forward sale price. The actual proceeds, if any, that we will be entitled to receive upon settlement of the forward sale agreements will depend on a number of factors, including the settlement method that is used and the price of our Class A common shares during the period between the time of this offering and the time of settlement of the forward sale agreements, which we expect to occur no later than January 20, 2023. Although we expect to settle the forward sale agreements entirely by the physical delivery of our Class A common shares in exchange for cash proceeds, we may elect cash settlement or net share settlement for all or a portion of our obligations under the forward sale agreements. See “Underwriting (Conflicts of Interest)—Sales Through Forward Sellers.” |
The Forward Purchasers, or their affiliates, have granted the underwriters the option, exercisable in whole or from time to time in part, to purchase up to an additional 3,000,000 Class A common shares at a price of $37.584 per Class A common share within 30 days from the date of this prospectus supplement. Upon any exercise of such option, we will enter into additional forward sale agreements with the Forward Purchasers. Unless the context requires otherwise, the term “forward sale agreement” as used in this prospectus supplement includes any additional forward sale agreements that we enter into in connection with the exercise, by the underwriters, of their option to purchase additional Class A common shares. In such event, if the Forward Purchasers or their respective affiliates do not deliver and sell all of the Class A common shares to be sold in connection with the exercise of such option, we will issue and sell to the underwriters a number of Class A common shares equal to the number of Class A common shares that such Forward Purchasers or their respective affiliates do not sell, and the number of Class A common shares underlying the forward sale agreements will be decreased by the number of Class A common shares that we issue and sell.
The Class A common shares will be ready for delivery on or about January 24, 2022.
Book-Running Managers
| | | | | | | | | | |
BofA Securities | | J.P. Morgan | | Citigroup | | Morgan Stanley |
Wells Fargo Securities | | Raymond James | | BMO Capital Markets | | Jefferies | | Mizuho Securities |
Co-Managers
| | | | | | | | |
BTIG | | RBC Capital Markets | | Regions Securities LLC | | Ramirez & Co., Inc. | | Scotiabank |
The date of this prospectus supplement is January 19, 2022.